129 related articles for article (PubMed ID: 1483552)
1. [Economic analysis of maintenance treatment with ranitidine 150 mg in duodenal ulcer].
Ruszniewski P; Levy E; Mignon M
Gastroenterol Clin Biol; 1992; 16(11):842-7. PubMed ID: 1483552
[TBL] [Abstract][Full Text] [Related]
2. [Intermittent treatment or preventive treatment of recurrence in duodenal ulcer disease? A controlled, double-blind study with 150 mg ranitidine daily for one year].
Mignon M; Ruszniewski P; Pappo M; Alberola B; Georges D
Gastroenterol Clin Biol; 1990; 14(10):732-8. PubMed ID: 2262119
[TBL] [Abstract][Full Text] [Related]
3. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group.
Sonnenberg A; Schwartz JS; Cutler AF; Vakil N; Bloom BS
Arch Intern Med; 1998 Apr; 158(8):852-60. PubMed ID: 9570170
[TBL] [Abstract][Full Text] [Related]
4. Pharmaco-economic considerations in the long-term management of peptic ulcer disease.
Ruszniewski P
Aliment Pharmacol Ther; 1993; 7 Suppl 2():41-8. PubMed ID: 8103375
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of alternative Helicobacter pylori eradication strategies in the management of duodenal ulcer.
O'Brien B; Goeree R; Hunt R; Wilkinson J; Levine M; William A
Can J Gastroenterol; 1997; 11(4):323-31. PubMed ID: 9218858
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer].
Di Mario F; Grasso GA; Battaglia G; De Boni M; Vianello F; De Bona M; Pasquino M; Chiozzini G; Saggioro A
Minerva Gastroenterol Dietol; 1993 Jun; 39(2):83-7. PubMed ID: 8364105
[TBL] [Abstract][Full Text] [Related]
7. Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.
Frampton JE; McTavish D
Pharmacoeconomics; 1994 Jul; 6(1):57-89. PubMed ID: 10147354
[TBL] [Abstract][Full Text] [Related]
8. [The recurrence of duodenal ulcer in patients undergoing treatment with ranitidine and placebo. A multicenter study].
Villalobos JJ; Nava AA; Elizondo J; Gallo S; Guerrero C; Vargas F; Barrera A; Centeno F; Marín E; Peña F
Rev Gastroenterol Mex; 1991; 56(2):65-9. PubMed ID: 1947617
[TBL] [Abstract][Full Text] [Related]
9. Long-term consequences with regard to clinical outcome and cost-effectiveness of episodic treatment with omeprazole or ranitidine for healing of duodenal ulcer.
Walan A; Eriksson S
Scand J Gastroenterol Suppl; 1994; 201():91-7. PubMed ID: 8047832
[TBL] [Abstract][Full Text] [Related]
10. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada.
O'Brien B; Goeree R; Mohamed AH; Hunt R
Arch Intern Med; 1995 Oct; 155(18):1958-64. PubMed ID: 7575049
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
Barradell LB; McTavish D
Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
[TBL] [Abstract][Full Text] [Related]
13. [Effect of enprostil on the healing and the recurrence of duodenal ulcer. Comparison with ranitidine].
Lartigue S; Corrion F; Bernades P; Bonfils S; Chevalier T; Laverdant C; Mignon M; Minaire Y; Pariente A; Vicari F
Gastroenterol Clin Biol; 1994; 18(6-7):617-22. PubMed ID: 7875419
[TBL] [Abstract][Full Text] [Related]
14. Seasonal behaviour of healed duodenal ulcer.
Gupta AK; Pal LS
J Indian Med Assoc; 1998 Apr; 96(4):106-8. PubMed ID: 9844330
[TBL] [Abstract][Full Text] [Related]
15. Ulcer healing and relapse prevention by ranitidine in peptic ulcer disease.
Liedberg G; Davies HJ; Enskog L; Eriksson S; Frederiksen B; Graffner H; Hradsky M; Oscarson J; Rydberg B; Simert G
Scand J Gastroenterol; 1985 Oct; 20(8):941-4. PubMed ID: 3909374
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer.
Van Deventer GM; Elashoff JD; Reedy TJ; Schneidman D; Walsh JH
N Engl J Med; 1989 Apr; 320(17):1113-9. PubMed ID: 2651924
[TBL] [Abstract][Full Text] [Related]
17. [Controlled study with ranitidine for the prevention of recurrent duodenal ulcer].
Ocaña Andrade E; Porras Katz JC; Beltrán Escobar G; Jáuregui Garduño JL
Rev Gastroenterol Mex; 1997; 62(2):94-7. PubMed ID: 9471669
[TBL] [Abstract][Full Text] [Related]
18. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
Tavakoli M; Prach AT; Malek M; Hopwood D; Senior BW; Murray FE
Pharmacoeconomics; 1999 Oct; 16(4):355-65. PubMed ID: 10623364
[TBL] [Abstract][Full Text] [Related]
19. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease.
Penston JG; Wormsley KG
Aliment Pharmacol Ther; 1992 Oct; 6(5):629-45. PubMed ID: 1420753
[TBL] [Abstract][Full Text] [Related]
20. Five-year maintenance treatment with ranitidine: effects on the natural history of duodenal ulcer disease.
Susi D; Neri M; Ballone E; Mezzetti A; Cuccurullo F
Am J Gastroenterol; 1994 Jan; 89(1):26-32. PubMed ID: 8273793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
